Search
for
Sort by
Research 541–570 of 1000+
- Pigmented contact dermatitis from topical minoxidil 5%
- Saturable Binding of Finasteride to Steroid 5α-reductase as Determinant of Nonlinear Pharmacokinetics
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- Directed Expression of a Chimeric Type II Keratin Partially Rescues Keratin 5-null Mice
- Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
- The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats
- The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia
- Equine 5α-reductase activity and expression in epididymis
- Subcellular localization of the five members of the human steroid 5α-reductase family
- Minoxidil 5% Solution for Topical Treatment of Loose Anagen Hair Syndrome
- Determination Method for Steroid 5α-Reductase Activity Using Liquid Chromatography/Atmospheric Pressure Chemical Ionization–Mass Spectrometry
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- The 5α-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- Scd1 ab-Xyk : a new asebia allele characterized by a CCC trinucleotide insertion in exon 5 of the stearoyl-CoA desaturase 1 gene in mouse
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- A one-year observational study with minoxidil 5% solution in Germany: results of independent efficacy evaluation by physicians and patients
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- <i>Eclipta prostrata</i> promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
- Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Stable transfection and identification of a hair follicle-specific expression vector of IGFBP-5 in goat fetal fibroblasts
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Hair Loss in a 5-Year-Old Boy
- A role for steroid 5 alpha-reductase 1 in vascular remodeling during endometrial decidualization
- Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride